Firmenbeschreibung
Illumina, Inc. ist ein US-amerikanisches Unternehmen, das im Bereich Genforschung tätig ist. Die Kernkompetenzen des Konzerns liegen auf der Entwicklung, Herstellung und Vermarktung von Life Science-Geräten und integrierten Systemen für die Analyse von genetischen Variationen und Funktionen. In diesem Zusammenhang werden innovative Sequenzierungs- und Array-basierte Lösungen für Genotypisierung, Variationsanalyse, Methylierung sowie Genprofilierung und DNA-, RNA- und Protein-Untersuchung in Studien zur Verfügung gestellt. Darüber hinaus enthält das Leistungsspektrum auch Services und Hilfsmittel im Bereich Genomik und Diagnostik. Dabei kommen die Lösungen und Produkte der Gesellschaft in vielfältigen Bereichen wie beispielsweise bei Pharma- und Biotechnologieunternehmen wie auch bei Regierungs- und Bildungsbehörden weltweit zum Einsatz. Im Wesentlichen dienen die Produkte und Technologien von Illumina der Erforschung von Genmaterial sowie einer schnellen Analyse und ebnen den Weg für molekulare Medizin. Nicht zuletzt werden durch DNA- und Protein-Analysen Fortschritte in der Erforschung von Krankheiten, Medikamenten und molekularen klinischen Tests ermöglicht.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | Vanguard Group Inc (9.87%),Baillie Gifford and Company (8.83%),Blackrock Inc. (8.51%),Morgan Stanley (4.77%),State Street Corporation (4.24%),Edgewood Management Llc (3.52%),Wellington Management Group, LLP (3.33%),Polen Capital Management, LLC (3.22%),Janus Henderson Group PLC (3.02%),Loomis Sayles & Company, LP (2.4%) |
sharesOutstanding: | 158900000.0000 |
ceo: | Charles Dadswell |
board: | Ankur Dhingra, Steve Barnard, Nicole Berry, Aimee Hoyt, Kevin Pegels, Li Qing, Kathryne Reeves, Carissa Rollins, Salli Schwartz, Susan Tousi, Bas Verhoef, Gretchen Weightman |
supervisoryBoard: | Stephen P. MacMillan, Frances Arnold, PhD, Caroline Dorsa, Robert S. Epstein, Scott Gottlieb, Gary S. Guthart, Philip Schiller, Sue Siegel, Andrew Teno, Scott B. Ullem |
countryID: | 20 |
freeFloat: | 48.2900 |
faceValue: | 0.0100 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Medizintechnische Produkte |
industryName: | Gesundheitswesen |
subsectorName: | Hochentwickelte medizinische Geräte |
country: | USA |
countryName: | USA |
Kontakt
phone: | +1-858-291-6421 |
email: | ir@illumina.com |
irWebSite: | https://investor.illumina.com/investors/default.aspx |
Adresse
street: | 5200 Illumina Way |
city: | San Diego, California 92122, USA |
phone: | +1-858-202-4500 |
fax: | +1-858-202-4766 |
webSite: | www.illumina.com/ |
email: | info@illumina.com |
Finanzen (kurz)
year: | 2021 | cash: | 1232.0000 |
balanceSheetTotal: | 15217.0000 | liabilities: | 4477.0000 |
shareCapital: | 2.0000 | totalShareholdersEquity: | 10740.0000 |
sales: | 4526.0000 | bankLoans: | -123.0000 |
investment: | 0.0000 | incomeBeforeTaxes: | 884.0000 |
netIncome: | 762.0000 | cashFlow: | -578.0000 |
employees: | 9100 | currencyID: | 4 |
units: | 1000000 | currency: | USD |
year: | 2022 | cash: | 2011.0000 |
balanceSheetTotal: | 12252.0000 | liabilities: | 5653.0000 |
shareCapital: | 2.0000 | totalShareholdersEquity: | 6599.0000 |
sales: | 4584.0000 | incomeBeforeTaxes: | -4336.0000 |
netIncome: | -4404.0000 | cashFlow: | 779.0000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2023 | cash: | 1048.0000 |
balanceSheetTotal: | 10111.0000 | liabilities: | 4366.0000 |
shareCapital: | 2.0000 | totalShareholdersEquity: | 5745.0000 |
sales: | 4504.0000 | incomeBeforeTaxes: | -1117.0000 |
netIncome: | -1161.0000 | cashFlow: | -963.0000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
Finanzen (kurz)
year: | 2021 |
cash: | 1232.0000 |
balanceSheetTotal: | 15217.0000 |
liabilities: | 4477.0000 |
shareCapital: | 2.0000 |
totalShareholdersEquity: | 10740.0000 |
sales: | 4526.0000 |
bankLoans: | -123.0000 |
investment: | 0.0000 |
incomeBeforeTaxes: | 884.0000 |
netIncome: | 762.0000 |
cashFlow: | -578.0000 |
employees: | 9100 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2022 |
cash: | 2011.0000 |
balanceSheetTotal: | 12252.0000 |
liabilities: | 5653.0000 |
shareCapital: | 2.0000 |
totalShareholdersEquity: | 6599.0000 |
sales: | 4584.0000 |
incomeBeforeTaxes: | -4336.0000 |
netIncome: | -4404.0000 |
cashFlow: | 779.0000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2023 |
cash: | 1048.0000 |
balanceSheetTotal: | 10111.0000 |
liabilities: | 4366.0000 |
shareCapital: | 2.0000 |
totalShareholdersEquity: | 5745.0000 |
sales: | 4504.0000 |
incomeBeforeTaxes: | -1117.0000 |
netIncome: | -1161.0000 |
cashFlow: | -963.0000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 12252.0000 | cash: | 2011.0000 |
currentAssets: | 3561.0000 | fixedAssets: | 8691.0000 |
liabilities: | 2773.0000 | totalLiabilitiesEquity: | 12252.0000 |
totalShareholdersEquity: | 6599.0000 | property: | 1091.0000 |
intangibleAssets: | 3285.0000 | inventories: | 568.0000 |
accountsReceivable: | 671.0000 | accountsPayable: | 293.0000 |
liabilitiesTotal: | 5653.0000 | longTermDebt: | 1487.0000 |
shortTermDebt: | 748.0000 | commonStock: | 2.0000 |
preferredStock: | 0.0000 | sales: | 4584.0000 |
netIncome: | -4404.0000 | operatingResult: | -4179.0000 |
incomeInterest: | 15.0000 | investments: | 1321.0000 |
incomeTaxes: | 68.0000 | costGoodsSold: | 1612.0000 |
grossProfit: | 2972.0000 | cashFlow: | 392.0000 |
cashFlowInvesting: | -591.0000 | cashFlowFinancing: | 1000.0000 |
cashFlowTotal: | 779.0000 | accountingStandard: | US GAAP |
equityRatio: | 53.8606 | debtEquityRatio: | 85.6645 |
liquidityI: | 72.5207 | liquidityII: | 96.7184 |
netMargin: | -96.0733 | grossMargin: | 64.8342 |
cashFlowMargin: | 8.5515 | ebitMargin: | -91.1649 |
ebitdaMargin: | 0.0000 | preTaxROE: | -65.7069 |
preTaxROA: | -35.3901 | roe: | -66.7374 |
roa: | -35.9452 | netIncomeGrowth: | -677.9528 |
revenuesGrowth: | 1.2815 | taxExpenseRate: | -1.5683 |
equityTurnover: | 0.6947 | epsBasic: | -28.0000 |
epsDiluted: | -28.0000 | epsBasicGrowth: | -652.2682 |
shareCapital: | 2.0000 | incomeBeforeTaxes: | -4336.0000 |
priceCashFlowRatio: | 81.4990 | bookValuePerShare: | 41.7658 |
marketCap: | 31947600000.0000 | earningsYield: | -13.8477 |
cashFlowPerShare: | 2.4810 | priceBookValueRatio: | 4.8413 |
netEarningsPerShare: | -27.8734 | currency: | USD |
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 10111.0000 | cash: | 1048.0000 |
currentAssets: | 2609.0000 | fixedAssets: | 7502.0000 |
liabilities: | 1570.0000 | totalLiabilitiesEquity: | 10111.0000 |
totalShareholdersEquity: | 5745.0000 | property: | 1007.0000 |
intangibleAssets: | 2993.0000 | inventories: | 587.0000 |
accountsReceivable: | 734.0000 | accountsPayable: | 245.0000 |
liabilitiesTotal: | 4366.0000 | longTermDebt: | 1489.0000 |
shortTermDebt: | 0.0000 | commonStock: | 2.0000 |
preferredStock: | 0.0000 | sales: | 4504.0000 |
netIncome: | -1161.0000 | operatingResult: | -1069.0000 |
incomeInterest: | 19.0000 | investments: | 1354.0000 |
incomeTaxes: | 44.0000 | costGoodsSold: | 1760.0000 |
grossProfit: | 2744.0000 | cashFlow: | 478.0000 |
cashFlowInvesting: | -231.0000 | cashFlowFinancing: | -1210.0000 |
cashFlowTotal: | -963.0000 | accountingStandard: | US GAAP |
equityRatio: | 56.8193 | debtEquityRatio: | 75.9965 |
liquidityI: | 66.7516 | liquidityII: | 113.5032 |
netMargin: | -25.7771 | grossMargin: | 60.9236 |
cashFlowMargin: | 10.6128 | ebitMargin: | -23.7345 |
ebitdaMargin: | 0.0000 | preTaxROE: | -19.4430 |
preTaxROA: | -11.0474 | roe: | -20.2089 |
roa: | -11.4825 | netIncomeGrowth: | -73.6376 |
revenuesGrowth: | -1.7452 | taxExpenseRate: | -3.9391 |
equityTurnover: | 0.7840 | epsBasic: | -7.3400 |
epsDiluted: | -7.3400 | epsBasicGrowth: | -73.7857 |
shareCapital: | 2.0000 | incomeBeforeTaxes: | -1117.0000 |
priceCashFlowRatio: | 46.2871 | bookValuePerShare: | 36.1548 |
marketCap: | 22125236000.0000 | earningsYield: | -5.2715 |
cashFlowPerShare: | 3.0082 | priceBookValueRatio: | 3.8512 |
netEarningsPerShare: | -7.3065 | currency: | USD |
year: | 2024 | priceCashFlowRatio: | 38.8557 |
bookValuePerShare: | 36.1548 | marketCap: | 18573026500.0000 |
earningsYield: | -6.2797 | pegRatio: | 0.2158 |
cashFlowPerShare: | 3.0082 | netAssetsPerShare: | 36.1548 |
priceBookValueRatio: | 3.2329 | netEarningsPerShare: | -7.3065 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 12252.0000 |
cash: | 2011.0000 |
currentAssets: | 3561.0000 |
fixedAssets: | 8691.0000 |
liabilities: | 2773.0000 |
totalLiabilitiesEquity: | 12252.0000 |
totalShareholdersEquity: | 6599.0000 |
property: | 1091.0000 |
intangibleAssets: | 3285.0000 |
inventories: | 568.0000 |
accountsReceivable: | 671.0000 |
accountsPayable: | 293.0000 |
liabilitiesTotal: | 5653.0000 |
longTermDebt: | 1487.0000 |
shortTermDebt: | 748.0000 |
commonStock: | 2.0000 |
preferredStock: | 0.0000 |
sales: | 4584.0000 |
netIncome: | -4404.0000 |
operatingResult: | -4179.0000 |
incomeInterest: | 15.0000 |
investments: | 1321.0000 |
incomeTaxes: | 68.0000 |
costGoodsSold: | 1612.0000 |
grossProfit: | 2972.0000 |
cashFlow: | 392.0000 |
cashFlowInvesting: | -591.0000 |
cashFlowFinancing: | 1000.0000 |
cashFlowTotal: | 779.0000 |
accountingStandard: | US GAAP |
equityRatio: | 53.8606 |
debtEquityRatio: | 85.6645 |
liquidityI: | 72.5207 |
liquidityII: | 96.7184 |
netMargin: | -96.0733 |
grossMargin: | 64.8342 |
cashFlowMargin: | 8.5515 |
ebitMargin: | -91.1649 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -65.7069 |
preTaxROA: | -35.3901 |
roe: | -66.7374 |
roa: | -35.9452 |
netIncomeGrowth: | -677.9528 |
revenuesGrowth: | 1.2815 |
taxExpenseRate: | -1.5683 |
equityTurnover: | 0.6947 |
epsBasic: | -28.0000 |
epsDiluted: | -28.0000 |
epsBasicGrowth: | -652.2682 |
shareCapital: | 2.0000 |
incomeBeforeTaxes: | -4336.0000 |
priceCashFlowRatio: | 81.4990 |
bookValuePerShare: | 41.7658 |
marketCap: | 31947600000.0000 |
earningsYield: | -13.8477 |
cashFlowPerShare: | 2.4810 |
priceBookValueRatio: | 4.8413 |
netEarningsPerShare: | -27.8734 |
currency: | USD |
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 10111.0000 |
cash: | 1048.0000 |
currentAssets: | 2609.0000 |
fixedAssets: | 7502.0000 |
liabilities: | 1570.0000 |
totalLiabilitiesEquity: | 10111.0000 |
totalShareholdersEquity: | 5745.0000 |
property: | 1007.0000 |
intangibleAssets: | 2993.0000 |
inventories: | 587.0000 |
accountsReceivable: | 734.0000 |
accountsPayable: | 245.0000 |
liabilitiesTotal: | 4366.0000 |
longTermDebt: | 1489.0000 |
shortTermDebt: | 0.0000 |
commonStock: | 2.0000 |
preferredStock: | 0.0000 |
sales: | 4504.0000 |
netIncome: | -1161.0000 |
operatingResult: | -1069.0000 |
incomeInterest: | 19.0000 |
investments: | 1354.0000 |
incomeTaxes: | 44.0000 |
costGoodsSold: | 1760.0000 |
grossProfit: | 2744.0000 |
cashFlow: | 478.0000 |
cashFlowInvesting: | -231.0000 |
cashFlowFinancing: | -1210.0000 |
cashFlowTotal: | -963.0000 |
accountingStandard: | US GAAP |
equityRatio: | 56.8193 |
debtEquityRatio: | 75.9965 |
liquidityI: | 66.7516 |
liquidityII: | 113.5032 |
netMargin: | -25.7771 |
grossMargin: | 60.9236 |
cashFlowMargin: | 10.6128 |
ebitMargin: | -23.7345 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -19.4430 |
preTaxROA: | -11.0474 |
roe: | -20.2089 |
roa: | -11.4825 |
netIncomeGrowth: | -73.6376 |
revenuesGrowth: | -1.7452 |
taxExpenseRate: | -3.9391 |
equityTurnover: | 0.7840 |
epsBasic: | -7.3400 |
epsDiluted: | -7.3400 |
epsBasicGrowth: | -73.7857 |
shareCapital: | 2.0000 |
incomeBeforeTaxes: | -1117.0000 |
priceCashFlowRatio: | 46.2871 |
bookValuePerShare: | 36.1548 |
marketCap: | 22125236000.0000 |
earningsYield: | -5.2715 |
cashFlowPerShare: | 3.0082 |
priceBookValueRatio: | 3.8512 |
netEarningsPerShare: | -7.3065 |
currency: | USD |
year: | 2024 |
priceCashFlowRatio: | 38.8557 |
bookValuePerShare: | 36.1548 |
marketCap: | 18573026500.0000 |
earningsYield: | -6.2797 |
pegRatio: | 0.2158 |
cashFlowPerShare: | 3.0082 |
netAssetsPerShare: | 36.1548 |
priceBookValueRatio: | 3.2329 |
netEarningsPerShare: | -7.3065 |
currency: | USD |